2',2'-dFdU,
2',2'-difluoro-2'-deoxyuridine,
2',2'-difluorodeoxyuridine,
114248-23-6,
2',2'-Difluoro-2'-deoxyuridine,
2'-Deoxy-2',2'-difluorouridine,
UNII-Y30D8SIL1I,
Uridine, 2'-deoxy-2',2'-difluoro-,
Y30D8SIL1I,
2',2'-Difluorodeoxyuridine,
Uridine,2'-deoxy-2',2'-difluoro-,
dFdU,
Gemcitabine metabolite,
Gemcitabine impurity C,
SCHEMBL94634,
Gemcitabine Impurity C (EP),
CHEMBL3526970,
CTK4A8651,
KS-00000MIY,
1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione,
FIRDBEQIJQERSE-QPPQHZFASA-N,
ZINC3792372,
MFCD00871912,
AKOS027326499,
AS-31170,
AB0071683,
FT-0666818,
J-700291,
1-(2-Deoxy-2,2-difluoro-beta-D-erythro-pentofuranosyl)pyrimidin-2,4(1H,3H)-dione,
1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione,
1-(2-Deoxy-2,2-difluoro-beta-D-erythro-pentofuranosyl)pyrimidin-2,4(1H,3H)-dione (2'-Deoxy-2',2'-difluorouridine),
2/',2/'-Difluorodeoxyuridine,
AIDS080589,
CID9871558,
153381-14-7,